Valuation: MedPacto, Inc.

Market Cap 90.83B 63.83M 55.28M 51.53M 47.4M 89.48M 6.07B 90.48M 606M 238M 3.04B 240M 234M 10.06B P/E 2024
-7.42x
P/E 2025 -17.9x
Enterprise Value 51.86B 36.44M 31.56M 29.42M 27.06M 51.08M 3.47B 51.65M 346M 136M 1.73B 137M 134M 5.74B EV / Sales 2024
-
EV / Sales 2025 48,733,025x
Free-Float
74%
Yield 2024 *
-
Yield 2025 -
1 day+1.15%
1 week+3.92%
Current month+12.77%
1 month-16.67%
3 months-49.52%
6 months-54.86%
Current year-60.33%
1 week 2,235
Extreme 2235
2,680
1 month 2,235
Extreme 2235
3,960
Current year 2,235
Extreme 2235
7,980
1 year 2,235
Extreme 2235
8,650
3 years 2,235
Extreme 2235
17,240
5 years 2,235
Extreme 2235
69,600
10 years 2,235
Extreme 2235
134,200
Manager TitleAgeSince
Chief Executive Officer 72 19/06/2013
President 66 28/03/2024
Corporate Officer/Principal 67 -
Director TitleAgeSince
Director/Board Member 72 19/06/2013
Director/Board Member 64 28/03/2024
Director/Board Member 74 28/03/2024
Date Insider Type Main position Quantity % Market Cap.
04/03/25 Buy 10,000 0.0292%
04/03/25 Buy 10,500 0.0306%
04/03/25 Buy

Chairperson

15,000 0.0438%
Change 5-day change 1-year change 3-year change Capi.($)
+1.15%+3.92%-36.75%-82.06% 63.83M
+4.35%+16.60%+58.11%+95.21% 64.9B
+1.68%+1.96%+30.66%+72.18% 54.05B
+0.91%-0.83%-17.01%-13.43% 23.16B
+0.27%-3.98%-11.28%+350.30% 21.46B
+1.87%+9.47%+30.87%-5.63% 21.25B
+0.70%+2.98%+37.91%-25.27% 17.94B
+9.88%+23.61%+222.87%+385.49% 17.03B
+3.29%+5.61%+21.01%+636.23% 14.99B
+1.25%+2.48%+51.36%+179.72% 14.25B
Average +1.62%+6.36%+38.77%+159.27% 24.91B
Weighted average by Cap. +2.21%+5.91%+44.03%+141.99%

Financials

2024 2025
Net sales - 3.9K 2.74 2.37 2.21 2.03 3.84 260.5 3.88 25.99 10.2 130.34 10.29 10.06 431.68
Net income -20.14B -14.15M -12.26M -11.43M -10.51M -19.84M -1.35B -20.06M -134M -52.7M -673M -53.16M -51.98M -2.23B -12.81B -9M -7.8M -7.27M -6.68M -12.62M -856M -12.76M -85.41M -33.52M -428M -33.81M -33.07M -1.42B
Net Debt -53.54B -37.62M -32.59M -30.38M -27.94M -52.74M -3.58B -53.33M -357M -140M -1.79B -141M -138M -5.93B -38.97B -27.39M -23.72M -22.11M -20.34M -38.39M -2.6B -38.82M -260M -102M -1.3B -103M -101M -4.32B
Logo MedPacto, Inc.
MedPacto, Inc. is a Korea-based company principally engaged in the research and development of biopharmaceuticals. The Company researches and develops anticancer drugs and diagnostic kits including vactosertib, MA-B2 and others. The products are used as the treatment of multiple myeloma, lung cancer, stomach cancer, colon cancer, blood cancer, triple negative breast cancer and pancreatic cancer, among others.
Employees
-
Date Price Change Volume
05/08/26 ₩2,650.00 +1.15% 125,092
04/08/26 ₩2,620.00 +6.94% 234,318
03/08/26 ₩2,450.00 +4.26% 271,668
31/07/26 ₩2,350.00 +4.91% 270,435
30/07/26 ₩2,240.00 -12.16% 628,594
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
CCC

Net sales - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A235980 Stock